Stroke prevention: a heart procedure did about as well as blood thinners
☕ Includes a question for the family ↓
StrokePart of a story we are following · 7 articles · See every update
If you live with atrial fibrillation, here is some calm, useful news about stroke. In a study of 1,290 older adults with atrial fibrillation who were at high risk of both stroke and bleeding, a heart procedure called left atrial appendage closure had about the same results as medicine for stroke, clots elsewhere in the body, and heart-related death.
That means there are two options that came out about even in this group. It also helps explain why the choice can feel confusing, and the sections below walk through it.
How the study worked
Researchers pooled the individual patient data from two randomized trials, CLOSURE-AF and PRAGUE-17, which compared the procedure (done through the skin, with no open surgery) against modern medical therapy. In all, 1,290 people took part: 647 were assigned to the procedure and 643 to the comparison group. Their median age was 77.3 years, and 62.7% were men. The analysis was published on October 29, 2026 in the J Am Coll Cardiol, and the authors note that only two trials were included, so longer follow-up is needed to sharpen the later results.
What they found
The main question was whether the procedure did as well as medicine at avoiding a stroke, a blood clot elsewhere in the body, or a heart-related death. It did. The problem happened to about 22% of people in the procedure group and about 21% in the medicine group. The exact figures were 21.9% and 20.7%. The researchers called that difference too small to count as real.
The second question was about major bleeding, which matters a lot for people who are also at risk of bleeding. Overall, it was also similar: 13.3% with the procedure and 12.4% with medicine.
Timing told a more detailed story. Early on, bleeding was more common with the procedure. After 1 year, major bleeding had happened to 9.4% of the procedure group and 6.0% of the medicine group. By 3 years the gap had narrowed to 13.2% versus 12.1%, and the researchers could not say that difference was real.
The team had hoped the procedure might show a bleeding advantage later on. By 3 years, that advantage had not appeared. They say more long-term data are needed to know what happens beyond that point.
Why does this feel confusing?
Because the answer has two parts. For the main goal, avoiding stroke-related problems, the procedure and medicine looked about the same. For bleeding, the two paths differ in when it tends to happen, with more of it in the first year after the procedure.
It can help to think of it as two roads to the same place. Neither road came out clearly ahead overall, but they have different bumps along the way. Which road suits you depends on your own health and what you and your care team decide together.
What you can do today
Take five minutes with your morning coffee and write down three things on a single sheet of paper: what you take now for atrial fibrillation, how it has been going for you, and one question for your next appointment, such as “What are the options for me, and why do you recommend this one?” Bring the page along. Keep taking your medicine as prescribed until you have had that conversation.
Talk about it at home
Sometimes the heart beats a little out of rhythm, and the blood inside can slow down and form tiny clumps, a bit like leaves gathering in a quiet corner of a pond. Scientists combined the results from many older adults and compared different ways of keeping those clumps from causing trouble. Overall, the ways worked about equally well, though each had its own bumps along the way.
Question for the table
Imagine the scientists had let each person choose their own group, and the healthiest people all ended up in the same group. Why would that make the results hard to trust, and how could flipping a coin to decide who goes where fix the problem?
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Cite this article
Mongevity Desk. Stroke prevention: a heart procedure did about as well as blood thinners. Mongevity. Published November 12, 2026. Accessed November 22, 2026. https://mongevity.science/heart/2026/11/stroke-prevention-heart-procedure-vs-blood-thinners/Mongevity Desk. Stroke prevention: a heart procedure did about as well as blood thinners [Internet]. Mongevity; 2026 Nov 12 cited 2026 Nov 22]. Available from: https://mongevity.science/heart/2026/11/stroke-prevention-heart-procedure-vs-blood-thinners/Mongevity Desk. (2026, November 12). Stroke prevention: a heart procedure did about as well as blood thinners. Mongevity. https://mongevity.science/heart/2026/11/stroke-prevention-heart-procedure-vs-blood-thinners/
<a href="https://mongevity.science/heart/2026/11/stroke-prevention-heart-procedure-vs-blood-thinners/">Stroke prevention: a heart procedure did about as well as blood thinners</a>
Free to share or quote with credit and a link.
Questions and answers
- What did this study compare?
- It compared a heart procedure called left atrial appendage closure with modern medical therapy in people with atrial fibrillation who were at high risk of both stroke and bleeding.
- Was the procedure better than medicine?
- No clear winner appeared. For stroke, clots elsewhere in the body, and heart-related death, results were about even: 21.9% with the procedure and 20.7% with medicine.
- What about bleeding?
- Overall bleeding was similar. It was higher with the procedure at 1 year (9.4% vs 6.0%), and the gap had narrowed by 3 years (13.2% vs 12.1%).
- How many people were in the study?
- The analysis pooled two randomized trials with 1,290 people in total, 647 in the procedure group and 643 in the comparison group.





